Bob Hopkins
Stock Analyst at B of A Securities
(0.68)
# 2,425
Out of 4,479 analysts
30
Total ratings
59.46%
Success rate
-22.14%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Neutral | $225 → $185 | $138.71 | +33.37% | 3 | Jun 3, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $6.31 | -28.68% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | n/a | $61.87 | - | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $103.20 | +28.88% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | n/a | $6.24 | - | 2 | Mar 10, 2021 | |
| AFIB Acutus Medical | Downgrades: Neutral | n/a | $0.03 | - | 2 | Jan 14, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | n/a | $436.24 | - | 3 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $177.09 | - | 1 | Sep 8, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $146.44 | - | 1 | Apr 22, 2020 | |
| NVRO Nevro | Upgrades: Buy | n/a | $8.61 | - | 3 | Mar 20, 2019 | |
| TNDM Tandem Diabetes Care | Upgrades: Neutral | n/a | $39.45 | - | 2 | Aug 24, 2018 | |
| MDT Medtronic | Maintains: Buy | n/a | $77.12 | - | 1 | Aug 22, 2018 | |
| BAX Baxter International | Maintains: Buy | n/a | $33.06 | - | 1 | May 22, 2018 | |
| BSX Boston Scientific | Maintains: Buy | n/a | $76.41 | - | 1 | Apr 5, 2018 | |
| BDX Becton, Dickinson and Company | Reinstates: Buy | n/a | $229.27 | - | 1 | Jan 19, 2018 | |
| GMED Globus Medical | Upgrades: Neutral | n/a | $67.92 | - | 1 | Nov 10, 2017 | |
| MMSI Merit Medical Systems | Initiates: Buy | n/a | $85.64 | - | 1 | Jul 20, 2017 |
Inspire Medical Systems
Jun 3, 2024
Maintains: Neutral
Price Target: $225 → $185
Current: $138.71
Upside: +33.37%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $6.31
Upside: -28.68%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: n/a
Current: $61.87
Upside: -
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $103.20
Upside: +28.88%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: n/a
Current: $6.24
Upside: -
Acutus Medical
Jan 14, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.03
Upside: -
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $436.24
Upside: -
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $177.09
Upside: -
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $146.44
Upside: -
Nevro
Mar 20, 2019
Upgrades: Buy
Price Target: n/a
Current: $8.61
Upside: -
Tandem Diabetes Care
Aug 24, 2018
Upgrades: Neutral
Price Target: n/a
Current: $39.45
Upside: -
Medtronic
Aug 22, 2018
Maintains: Buy
Price Target: n/a
Current: $77.12
Upside: -
Baxter International
May 22, 2018
Maintains: Buy
Price Target: n/a
Current: $33.06
Upside: -
Boston Scientific
Apr 5, 2018
Maintains: Buy
Price Target: n/a
Current: $76.41
Upside: -
Becton, Dickinson and Company
Jan 19, 2018
Reinstates: Buy
Price Target: n/a
Current: $229.27
Upside: -
Globus Medical
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $67.92
Upside: -
Merit Medical Systems
Jul 20, 2017
Initiates: Buy
Price Target: n/a
Current: $85.64
Upside: -